1. Home
  2. Labeler Index
  3. Sanofi Pasteur Inc.
  4. NDC Product Code: 49281-250 Imovax Rabies

NDC 49281-250 Imovax Rabies

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 49281-250?
  4. Imovax Rabies Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk
  8. Patient Education

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Get all the details for National Drug Code (NDC) 49281-250 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
49281-250
Proprietary Name:
Imovax Rabies
Product Type: [3]
Labeler Name: [5]
Sanofi Pasteur Inc.
Labeler Code:
49281
Product Label ID:
ba8d4e72-f452-4859-ae6f-3644b4b0a78c
FDA Application Number: [6]
BLA103931
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date: [9]
06-09-1980
End Marketing Date: [10]
12-07-2021
Listing Expiration Date: [11]
12-07-2021
Exclude Flag: [12]
D
Code Navigator:

Code Structure Chart

Product Details

What is NDC 49281-250?

The NDC code 49281-250 is assigned by the FDA to the product Imovax Rabies which is product labeled by Sanofi Pasteur Inc.. The product's dosage form is . The product is distributed in a single package with assigned NDC code 49281-250-51 1 kit in 1 package * 1 ml in 1 vial, single-use (49281-248-58) * 1 ml in 1 syringe (49281-249-01). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Imovax Rabies?

Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups.

Which are Imovax Rabies UNII Codes?

The UNII codes for the active ingredients in this product are:

  • RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) (UNII: C4HQF74XMW)
  • RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) (UNII: C4HQF74XMW) (Active Moiety)

Which are Imovax Rabies Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Imovax Rabies?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 830467 - rabies virus vaccine (generic for Imovax) 2.5 UNT in 1 ML Injection
  • RxCUI: 830467 - 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection
  • RxCUI: 830467 - rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT per 1 ML Injection
  • RxCUI: 830470 - IMOVAX rabies vaccine 2.5 UNT in 1 ML Injection
  • RxCUI: 830470 - 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection [Imovax]

* Please review the disclaimer below.

Patient Education

Rabies Vaccine


What is rabies? Rabies is a serious disease. It is caused by a virus. Rabies is mainly a disease of animals. Humans get rabies when they are bitten by infected animals. At first there might not be any symptoms. But weeks, or even years after a bite, rabies can cause pain, fatigue, headaches, fever, and irritability. These are followed by seizures, hallucinations, and paralysis. Rabies is almost always fatal. Wild animals, especially bats, are the most common source of human rabies infection in the United States. Skunks, raccoons, dogs, and cats can also transmit the disease. Human rabies is rare in the United States. There have been only 55 cases diagnosed since 1990. However, between 16,000 and 39,000 people are treated each year for possible exposure to rabies after animal bites. Also, rabies is far more common in other parts of the world, with about 40,000 to 70,000 rabies-related deaths each year. Bites from unvaccinated dogs cause most of these cases. Rabies vaccine can prevent rabies.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".